GSK Benlysta gets European nod for treatment of children with lupus Medical Dialogues Bureau4 Nov 2019 9:15 AM ISTNew Delhi: GlaxoSmithKline (GSK) plc recently announced that the European Commission has adopted a decision to extend to children five years and...
GSK gets USFDA nod for Benlysta to treat pediatric patients with lupus Medical Dialogues Bureau30 April 2019 9:15 AM ISTNew Delhi: GlaxoSmithKline (GSK) has won the US Food and Drug Administration's (USFDA) approval for its Benlysta (belimumab) intravenous (IV) infusion...